Follow-The-Filings

Security · featured owners

ABCL Abcellera Biologics Inc

Abcellera Biologics Inc. Health Care COM Equity among managers we track

ABCL (Abcellera Biologics Inc) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 19 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
424B5 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 15 rows shown

Filed Form Detail Links
4 Period Aug 24, 2026 Filing Doc
4 Period Aug 18, 2026 Filing Doc
4 Period Aug 12, 2026 Filing Doc
4 Period Aug 14, 2026 Filing Doc
4 Period Aug 11, 2026 Filing Doc
4 Period Jul 1, 2026 · 2 forms Filing Doc
4 Period Jun 11, 2026 · 3 forms Filing Doc
4 Period Jun 3, 2026 Filing Doc
4 Period May 14, 2026 Filing Doc
4 Period Feb 27, 2026 Filing Doc
4 Period Feb 27, 2026 Filing Doc
4 Period Feb 26, 2026 Filing Doc
4 Period Jan 1, 2026 · 4 forms Filing Doc
4 Period Dec 18, 2025 Filing Doc
4 Period Dec 1, 2025 Filing Doc

Updated 5 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $38.02M $28.83M $75.13M
Net income -$146.4M -$162.86M -$146.41M
Net margin * -385.0% -564.8% -194.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $871.98M $751.37M $728.23M
Total non-current assets $616.11M $609.18M $628.72M
Total assets $1.49B $1.36B $1.36B
Total current liabilities $119.01M $76.61M $64.31M
Total non-current liabilities $216.76M $227.86M $325.74M
Total equity $1.15B $1.06B $0.967B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$43.88M -$108.56M -$131.3M
Cash from investing -$221.11M $121.41M $87.75M
Cash from financing $10.36M $12.77M $14.08M
Net change in cash -$254.04M $23M -$28.37M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders